These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32151463)

  • 21. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
    Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
    Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model.
    Hansen J; Jensen KT; Follmann F; Agger EM; Theisen M; Andersen P
    J Infect Dis; 2008 Sep; 198(5):758-67. PubMed ID: 18652549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.
    Caldwell HD; Kromhout J; Schachter J
    Infect Immun; 1981 Mar; 31(3):1161-76. PubMed ID: 7228399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge.
    Cheng C; Pal S; Tifrea D; Jia Z; de la Maza LM
    Microbes Infect; 2014 Mar; 16(3):244-52. PubMed ID: 24291713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics.
    Liu X; Afrane M; Clemmer DE; Zhong G; Nelson DE
    J Bacteriol; 2010 Jun; 192(11):2852-60. PubMed ID: 20348250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge.
    Bulir DC; Liang S; Lee A; Chong S; Simms E; Stone C; Kaushic C; Ashkar A; Mahony JB
    Vaccine; 2016 Jul; 34(34):3979-85. PubMed ID: 27325352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection.
    Berry LJ; Hickey DK; Skelding KA; Bao S; Rendina AM; Hansbro PM; Gockel CM; Beagley KW
    Infect Immun; 2004 Feb; 72(2):1019-28. PubMed ID: 14742549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model.
    Olsen AW; Theisen M; Christensen D; Follmann F; Andersen P
    PLoS One; 2010 May; 5(5):e10768. PubMed ID: 20505822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with the polymorphic membrane protein A reduces Chlamydia muridarum induced genital tract pathology.
    Müller T; Becker E; Stallmann S; Waldhuber A; Römmler-Dreher F; Albrecht S; Mohr F; Hegemann JH; Miethke T
    Vaccine; 2017 May; 35(21):2801-2810. PubMed ID: 28413133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.
    Kari L; Whitmire WM; Crane DD; Reveneau N; Carlson JH; Goheen MM; Peterson EM; Pal S; de la Maza LM; Caldwell HD
    J Immunol; 2009 Jun; 182(12):8063-70. PubMed ID: 19494332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved protection against Chlamydia muridarum using the native major outer membrane protein trapped in Resiquimod-carrying amphipols and effects in protection with addition of a Th1 (CpG-1826) and a Th2 (Montanide ISA 720) adjuvant.
    Tifrea DF; Pal S; le Bon C; Cocco MJ; Zoonens M; de la Maza LM
    Vaccine; 2020 Jun; 38(28):4412-4422. PubMed ID: 32386746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
    Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.
    Su H; Morrison RP; Watkins NG; Caldwell HD
    J Exp Med; 1990 Jul; 172(1):203-12. PubMed ID: 1694217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance.
    Desclozeaux M; Robbins A; Jelocnik M; Khan SA; Hanger J; Gerdts V; Potter A; Polkinghorne A; Timms P
    PLoS One; 2017; 12(6):e0178786. PubMed ID: 28575080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial protection against chlamydial reproductive tract infection by a recombinant major outer membrane protein/CpG/cholera toxin intranasal vaccine in the guinea pig Chlamydia caviae model.
    Andrew DW; Hafner LM; Beagley KW; Timms P
    J Reprod Immunol; 2011 Sep; 91(1-2):9-16. PubMed ID: 21856018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of outbred mice against a vaginal challenge by a
    Pal S; Ausar SF; Tifrea DF; Cheng C; Gallichan S; Sanchez V; de la Maza LM; Visan L
    Hum Vaccin Immunother; 2020 Oct; 16(10):2537-2547. PubMed ID: 32118511
    [No Abstract]   [Full Text] [Related]  

  • 40. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.
    Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.